Navigation Links
Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
Date:8/24/2009

Division Vice President, General Manager for the $1 billion anti-infective franchise.

Mr. Booth holds a BS in Biology from Northern Illinois University and an MBA from Northwestern University Kellogg School of Management.

About Orexigen((R)) Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead investigational product, Contrave((R)), has completed Phase 3 clinical trials and is on track for a regulatory submission with the FDA in the first half of 2010. The Company's second product candidate, Empatic(TM), is in the later stages of Phase 2 clinical development, with results expected in the second half of 2009. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches. Further information about the Company can be found athttp://www.Orexigen.com.


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference
2. Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
3. Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions
4. Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings
5. Orexigen(R) Therapeutics to Present at Upcoming Meetings
6. Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
7. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
8. Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
9. Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
10. Orexigen(R) Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008
11. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)... Imagine a polka-dotted postage stamp that can sn... changing colors. , As reported in the Sept. 13 ...uslick and his team at the University of Illinois ...detection of toxic industrial chemicals (TICs) tha...sualizing odors. This sensor array could be usefu...
(Date:11/18/2009)...er,s experience in data analysis combined with Bio... kits and curricula provide state-of-the-art s...TON, Ore., Nov. 18 Vernier Softwar...nce interfaces, sensors, and software and Bio-Rad ...nd distributor of life science research and clinic...
(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...
(Date:11/18/2009)... SPRINGS, Fla., Nov. 18 Algenol Bi...technology, and the technology group The Linde G...ment project in order to identify the optimum mana... Algenol,s unique algae and photobioreactor techno... forces to develop cost-efficient technologies tha...
Breaking Biology Technology:Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
...Epicurian Coli XL1-Red cells allow isolation of ...T. Bornscheuer Markus M.,Enzelberger ,Insti...ttgart, Stuttgart,Germany , Josef Altenbuchne... of Stuttgart, Stuttgart,Germany , Hartmut H....ity of Hannover, Hannover, Germany , Mutants of ...
...Easy RNA purification with integrated DNA-removal ...ne , The StrataPrep total RNA miniprep kit eff... 5 to 10 7 cultured,cells or 10 to 40 mg of ...,Additionally, multiple samples can be processed...chnique. The RNA isolation is performed within mic...
... , ,,, ,Determine retrovira...,virtually any target cell line , Brenda Rog...gene , We describe three new ViraPort retroviral...cZ , ,and pFB-Luc ,which can ...ene expression in,virtually any target cell line...
Other Biology Technology:Using XL1-Red Mutator Strain to Generate Esterase Variants 2Using XL1-Red Mutator Strain to Generate Esterase Variants 3Using XL1-Red Mutator Strain to Generate Esterase Variants 4Using XL1-Red Mutator Strain to Generate Esterase Variants 5Simple Isolation of RNA from Tissue and Cultured Cells 2Simple Isolation of RNA from Tissue and Cultured Cells 3Simple Isolation of RNA from Tissue and Cultured Cells 4Simple Isolation of RNA from Tissue and Cultured Cells 5Simple Isolation of RNA from Tissue and Cultured Cells 6Simple Isolation of RNA from Tissue and Cultured Cells 7Simple Isolation of RNA from Tissue and Cultured Cells 8Versatile Reporter Vectors for Monitoring Viral Transduction 2Versatile Reporter Vectors for Monitoring Viral Transduction 3Versatile Reporter Vectors for Monitoring Viral Transduction 4Versatile Reporter Vectors for Monitoring Viral Transduction 5Versatile Reporter Vectors for Monitoring Viral Transduction 6
(Date:11/20/2009)... Using highly precise measurements of plasma lipop...ic resonance spectroscopy (NMR), researchers led b...nd Harvard Medical School in Boston, MA, the Frami... consortium in Stockholm, Sweden and Oxford, Engla...he whole genome among 17,296 women of European anc...
(Date:11/20/2009)... North Grafton, Mass., November 19, 2009 The esti... industry may be at risk of developing respiratory...according to a questionnaire study undertaken earl...,s Cummings School of Veterinary Medicine. , The...barn workersfound that 50 percent of individuals w...
(Date:11/20/2009)... Surplus biomass from the production of flax shive...w-flowered plant related to those which engulf fie...This has been suggested by two studies carried out... the journal Renewable and Sustainable Energy Rev...mental point of view, the production of bioethanol...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 1New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 1M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 2M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 3M D Anderson redefines screening guidelines for breast cervical and colorectal cancers 60091 4Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3
... NY) ─ For the third time in 14 months, the ...nstein College of Medicine of Yeshiva University f...aling $12.7 million, will help create technologies...d liver disease, as well as obesity and hepatitis....r restoring federal funding for stem cell research...
...rsity of Miami,s Rosenstiel School of Marine and A...ected Rosalind E.M. Rickaby, Ph.D., as recipient o... in Biogeochemistry and a Tutorial Fellow of Wolfs...th Sciences at the University of Oxford. Her curre...oplankton and dissolved carbon dioxide in the ocea...
... the toxoplasmosis parasite may trigger the develo.... , The team from the University of Leeds, Facult...arasite may play a role in the development of thes...e - the chemical that relays messages in the brain...haviour. , Toxoplasmosis, which is transmitted vi...
Other Biology News:Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 2Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine 3Oxford's Dr. Rosalind Rickaby receives 2009 Rosenstiel Award 2Oxford's Dr. Rosalind Rickaby receives 2009 Rosenstiel Award 3Research supports toxoplasmosis link to schizophrenia 2
...m for fluorescent light due to small pixel size. E... level light in animals or plants in tumor researc...ircadian rhythm, gels and Western blots. NightOWL ...de the light-tight cabinet. This function allows c...
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-SF3B2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Biology Products: